E5H-88779-32621
4 vaccinations
6 coded responses
14 check-ins
5 free-text entries
3 call cases
- Sex
- Female
- Age at first dose
- 61-65
- ZIP prefix
- 974 / OR
- Registered
- 2021-08-19
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-01-25
Dose 1 — Moderna
-
2021-03-01
Dose 2 — Moderna
-
2021-08-17
Dose 3 — Moderna
-
2021-08-19
Registered in v-safe
-
2021-08-20
Survey response — days 1–6 daily, dose 3MedDRA: Unevaluable event — Feeling: Good · Site: Pain, Redness, Swelling, ItchingFree text: Birthdate should be (b)(6). Not (b)(6)MedDRA releases: 2021-09,2024-11 · check-in free text available
-
2021-08-22
Health check-in — days 1–6 daily, dose 3Feeling: Good · Site: Pain, Redness, Swelling, Itching · NoneAdult check-in
-
2021-08-23
Health check-in — days 1–6 daily, dose 3Feeling: Good · Site: Pain, Redness, Swelling, Itching · NoneAdult check-in
- 2021-09-07
- 2021-09-23
- 2021-09-28
-
2021-11-16
Survey response — 3 months, dose 3MedDRA: Asthma, Nasopharyngitis, Pre-existing disease, Respiratory tract infection viral — Feeling: Good · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Asthma exacerbation in September. Treated with a course of prednisone. October16th, Viral respiratory infection exacerbated asthma. Treated with prednisone. Caught cold from 8 yr old granddaughter. She tested negative for COVID.MedDRA releases: 2024-11 · check-in free text available
-
2021-11-16
Report sent to call center — 3 months, dose 3Be unable to do your normal daily activities · Get care from a doctor or other healthcare professionalOutpatient clinic or urgent care clinic visit · 1 call case(s)
- 2021-11-19
-
2022-02-17
Survey response — 6 months, dose 3MedDRA: Exposure to SARS-CoV-2 — Feeling: Good · Be unable to do your normal daily activitiesFree text: Exposed to COVID while caring for positive Covid elderly parents.MedDRA releases: 2024-11 · check-in free text available
-
2022-03-14
Dose 4 — Pfizer-BioNTech
-
2022-04-14
Survey response — day 28, dose 4MedDRA: Fatigue, Rhinorrhoea — Feeling: PoorFree text: Runny nose tired very tiredMedDRA releases: 2024-11 · check-in free text available
- 2022-04-18
- 2022-04-25
- 2022-06-14
-
2022-09-14
Survey response — 6 months, dose 4MedDRA: Chills, Diarrhoea, Hyperhidrosis, Nausea, Pain, Pyrexia, SARS-CoV-2 test negative, Vomiting — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: Nausea vomiting diarrhea chills sweats fever body aches. Negative COVID test.MedDRA releases: 2024-11 · check-in free text available
-
2022-09-14
Report sent to call center — 6 months, dose 4Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prTelehealth, virtual health, or email health consultation · 1 call case(s)
- 2022-09-15
- 2022-09-15
-
2023-03-14
Survey response — 12 months, dose 4MedDRA: Foot fracture, Nasopharyngitis, Ovarian lesion excision, Pancreatitis, SARS-CoV-2 test negative — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Emergency room or emergency department visit, HospitalizationMedDRA releases: 2024-11
-
2023-03-14
Report sent to call center — 12 months, dose 4Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prEmergency room or emergency department visit · Hospitalization · 1 call case(s)
- 2023-03-15
- 2023-03-15
- 2023-03-15
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-01-25 | Moderna | No |
| 2 | 2021-03-01 | Moderna | No |
| 3 | 2021-08-17 | Moderna | No |
| 4 | 2022-03-14 | Pfizer-BioNTech | No |
Call center
3 call center cases
3 unsuccessful
Free text
Release 9 — days 1–6 daily, dose 3
Release 10 — 3 months, dose 3
Symptoms: Asthma exacerbation in September. Treated with a course of prednisone. October16th, Viral respiratory infection exacerbated asthma. Treated with prednisone. Caught cold from 8 yr old granddaughter. She tested negative for COVID.
Release 11 — 6 months, dose 3
Symptoms: Exposed to COVID while caring for positive Covid elderly parents.
Release 11 — day 28, dose 4
Symptoms: Runny nose tired very tired
Release 12 — 6 months, dose 4
Symptoms: Nausea vomiting diarrhea chills sweats fever body aches. Negative COVID test.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Asthma | · | · | ✓ |
| SD | Chills | · | · | ✓ |
| SD | Diarrhoea | · | · | ✓ |
| SD | Exposure to SARS-CoV-2 | · | · | ✓ |
| SD | Fatigue | · | · | ✓ |
| SD | Foot fracture | · | · | ✓ |
| SD | Hyperhidrosis | · | · | ✓ |
| SD | Nasopharyngitis | · | · | ✓ |
| SD | Nausea | · | · | ✓ |
| SD | Ovarian lesion excision | · | · | ✓ |
| SD | Pain | · | · | ✓ |
| SD | Pancreatitis | · | · | ✓ |
| SD | Pre-existing disease | · | · | ✓ |
| SD | Pyrexia | · | · | ✓ |
| SD | Respiratory tract infection viral | · | · | ✓ |
| SD | Rhinorrhoea | · | · | ✓ |
| SD | SARS-CoV-2 test negative | · | · | ✓ |
| SD | Vomiting | · | · | ✓ |
| SRO | Unevaluable event | ✓ | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release